![](https://truthinadvertising.org/wp-content/uploads/2021/12/Robitussin-Severe-Multi-Symptom-Cough-Cold-Flu.jpg)
Robitussin Cough Medicine with DXM
Allegations: Falsely marketing medicine as “Non-Drowsy” when the active ingredient causes drowsiness
In September 2017, a class-action lawsuit was filed against Pfizer for allegedly misleadingly marketing Maximum Strength Robitussin Cough+Chest Congestion DM to make consumers believe that the maximum strength product contains more of the active ingredients than the regular strength product when, according to the plaintiffs, the two products contain the same amount of one of the active ingredients (expectorant) and the regular strength products contains more of the other active ingredient (cough suppressant). (Haj et al v. Pfizer Inc., Case No. 17-cv-6730, N.D. Ill.)
For more information about other class-action lawsuits regarding cough medicines and TINA.org’s coverage of the products, click here.
Allegations: Falsely marketing medicine as “Non-Drowsy” when the active ingredient causes drowsiness
Allegations: Misleadingly marketing the ingredients in and the health benefits provided by products
Allegations: Falsely marketing that medicines treat congestion
Allegations: Falsely marketing that medicines relieve nasal congestion and sinus pressure
Allegations: Falsely marketing medicines as nasal decongestants
Allegations: Falsely marketing that medicines relieve nasal congestion
Allegations: False natural claims
Allegations: Falsely marketing products as non-drowsy when an ingredient in them causes drowsiness
Allegations: Deceptively marketing products as “Maximum Strength” when the dosage of the active ingredients is less than or the same as the regular strength products
In December 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare Holdings and Pfizer for allegedly falsely advertising ChapStick products as natural when, according to plaintiffs, the products contain…
December 2018: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. September 2016: A class-action…
In October 2016, a federal court dismissed a false advertising class-action lawsuit filed against Pfizer in 2015. The complaint had alleged that the company misleadingly uses You know when you…
March 2016: A federal judge denied plaintiff’s request for permission to file a second amended complaint finding that the amended complaint would not survive a motion to dismiss and, as…
Pfizer overstated the benefits and efficiency of a popular antibiotic in a direct-to-consumer advertising campaign.
Oregon requiring Pfizer to get ads approved by FDA because of violations.
The polio vaccine, penicillin, open-heart surgery, magnetic resonance imaging, chemotherapy, Zoloft, LASIK, statins, heck, even Viagra have all contributed to the advancement of modern medicine. We’ve come a long way…